Skip to content
WeighLab
Menu
Ranked #290 · Grade C

Willow review

Telehealth provider offering compounded GLP-1 medications in both tablet and injectable formats.

Visit Willow Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$299/mo (starting dose, compounded)
Tirzepatide
$399/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$3,588

Tirzepatide · modeled / year

$4,788

The Index scorecard

Willow scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month43/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options77/100
Clinical Oversight71/100
Contract Flexibility55/100

Where the value is

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

The tradeoffs

  • Limited public information on program details

The bottom line

Best for: Cost-first shoppers who want mainstream telehealth GLP-1 access. Telehealth provider offering compounded GLP-1 medications in both tablet and injectable formats.

Ranked #290 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Willow.

The 20 programs nearest this one

Pricing, states and verification reflect Willow's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Willow's site. Not medical advice; see our disclosure.

← Back to the value leaderboard